Inhibitex, Inc. Files $125 Million Mixed Shelf
WASHINGTON, Oct 19 (Reuters) - Biopharmaceutical company Inhibitex Inc. (INHX.O: Quote, Profile, Research) may periodically sell up to $125 million in common stock and warrants, according to a regulatory filing on Wednesday.